ICON4/AGO-OVAR-2.2: questions about trial design, cost-effectiveness, and clinical benefit

Authors :: Gunnar B. Kristensen
Richard Gray
Nicoletta Colombo
John Green
Andreas du Bois
Keith Wheatley
Geoff Newman
Jonathan A. Ledermann
Valter Torri
Source :: The Lancet. 362:1333
Publication Year :: 2003
Publisher :: Elsevier BV, 2003.

Subjects :: Cost effectiveness
business.industry
Medicine
Operations management
General Medicine
business

Full Text Access

Tools